Free Trial

Assura Plc (LON:AGR) Insider Jayne Cottam Sells 94,230 Shares

Assura logo with Real Estate background

Assura Plc (LON:AGR - Get Free Report) insider Jayne Cottam sold 94,230 shares of Assura stock in a transaction on Tuesday, July 22nd. The shares were sold at an average price of GBX 50 ($0.67), for a total value of £47,115 ($63,318.10).

Jayne Cottam also recently made the following trade(s):

  • On Wednesday, July 9th, Jayne Cottam bought 607 shares of Assura stock. The shares were acquired at an average cost of GBX 50 ($0.67) per share, for a total transaction of £303.50 ($407.88).
  • On Tuesday, May 6th, Jayne Cottam bought 306 shares of Assura stock. The shares were acquired at an average cost of GBX 49 ($0.66) per share, for a total transaction of £149.94 ($201.51).

Assura Price Performance

Shares of AGR traded down GBX 0.37 ($0.00) during midday trading on Friday, reaching GBX 49.98 ($0.67). The stock had a trading volume of 7,478,144 shares, compared to its average volume of 27,833,574. Assura Plc has a 52 week low of GBX 35.24 ($0.47) and a 52 week high of GBX 50.95 ($0.68). The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. The firm's 50 day moving average price is GBX 49.80 and its 200-day moving average price is GBX 45.78. The company has a market capitalization of £1.63 billion, a P/E ratio of -47.77, a P/E/G ratio of 3.60 and a beta of 0.37.

Assura (LON:AGR - Get Free Report) last posted its quarterly earnings data on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) EPS for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. On average, analysts forecast that Assura Plc will post 3.5830389 earnings per share for the current fiscal year.

Assura Company Profile

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.

See Also

Insider Buying and Selling by Quarter for Assura (LON:AGR)

Should You Invest $1,000 in Assura Right Now?

Before you consider Assura, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.

While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines